Emergency department visits for pediatric concussion by material deprivation, age, and sex, in Ontario, Canada, 2010-2020: a population-based study
Macpherson A, Harkins J, Sergio L, Sadrmanesh O, Emery C, Rothman L. Inj Prev. 2025 Jul 11.
Publications
Assessing the impact of the introduction of generic methadone to the Ontario public drug formulary
Hamzat B, Wang T, Garg R, Iacono A, Tadrous M, Wu F, Wyman J, Dodd Z, Pinkerton S, Smoke A, Gomes T. Int J Drug Policy. 2025; 143:104918. Epub 2025 Jul 10.
A longitudinal analysis of the economic cost of all phases of TB care in a low incidence setting
Ramsay LC, Brode SK, Rea E, Barrett K, Hernandez A, Iragorri N, Liu K, Macdonald L, Sander B. IJTLD Open. 2025; 2(7):404-411.
Patterns of antepartum care in Ontario before and during a time of COVID-19 and virtual care: a population-based study
Lapinsky SC, Baxter NN, Sutradhar R, Everett K, Porter J, Yudin MH, Shore EM, Berger H, Campbell DM, Snelgrove JW, Simpson AN. Womens Health Issues. 2025; S1049-3867(25)00072-6. Epub 2025 Jul 8.
Marginalized neighborhoods and health outcomes in younger myocardial infarction survivors
Akioyamen LE, Sivaswamy A, Haldenby O, Abdel-Qadir H, Sud M, Alter DA, Atzema CL, Austin PC, Jackevicius CA, Kapral MK, Krumholz HM, Tu K, Wijeysundera HC, Ko DT. JAMA Netw Open. 2025; 8(7):e2518826.
Duration of methadone and buprenorphine-naloxone treatment
Kleinman RA, Kurdyak P. JAMA Netw Open. 2025; 8(7):e2518389.
COVID-19 vaccine uptake in a retrospective population-based cohort of people living with and without HIV in Ontario, Canada
Freitas C, Cooper CL, Kroch AE, Moineddin R, Arbess G, Benoit AC, Buchan SA, Chambers C, Habanyama M, Kendall CE, Kwong JC, Mbuagbaw L, McCullagh J, Moqueet N, Nambiar D, Rueda S, Tran V, Walmsley S, Burchell AN; CHESS Study Team. Vaccine. 2025; 61:127422. Epub 2025 Jul 1.
Abortion ratios after first-trimester exposure to teratogenic medication in people with disabilities
Camden A, Sharpe I, Lu H, Brown HK. Epidemiology. 2025; Mar 24 [Epub ahead of print].
Retention in opioid agonist therapy among First Nations people in Ontario, Canada: a retrospective cohort study
Holton A, Hamzat B, McCormack D, Bragg S, deGonzague B, Mecredy G, Campbell T, Antoniou T, McGregor L, Bertram J, Gomes T. JAMA Netw Open. 2025; 8(6):e2518452.
Changing trends in safer opioid supply uptake, dose and hydromorphone volume in Ontario: a population-based cross-sectional study
Xu F, Wang T, Kolla G, Campbell T, Watts T, Ledlie S, Koncz D, Tadrous M, Gomes T. Int J Drug Policy. 2025; 143:104905. Epub 2025 Jun 28.